Calidi Biotherapeutics’ $2.1 Million Shares Offering

Sichenzia Ross Ference Carmel advised Calidi Biotherapeutics, Inc., while Sheppard Mullin advised Ladenburg Thalmann & Co, Inc. on the offering.Calidi Biotherapeutics, Inc. has entered into a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here